Peer-reviewed Studies and the FDA
In 1990, a study was published in the New England Journal of Medicine addressing the use of HGH injections on older individuals. Over 6 months, 12 men experienced a decrease in fatty tissue and an increase in muscle mass while using the hormone. However, they experienced many side effects. Following the study, a large number of products began to hit the shelves, and the HGH fury has been raging ever since. In response to many physicians and marketers using this study as a basis for the use of HGH, the New England Journal of Medicine fought back. The Editor-in-Chief penned and published an article renouncing the use of previously published findings as a basis for justifying the use of HGH for anything other than treatment for HGH deficiency.
The FDA has also taken action against those who create and sell these products. In at least 10 cases, doctors and the owners of manufacturing companies have been fined and even jailed or put on probation for claiming that similar products worked to decrease aging and increase muscle mass.
While it may be tempting to dip into the fountain of youth, the positive effects of these products have yet to be verified by peer-reviewed studies and should be avoided. The potential damage to the body may be severe, and eager youth-seekers can put their money instead toward other treatments that can help them receive the results they desire.